A Study to Evaluate the Safest Dose Range for FEIBA in Hemophilia A Patients With Inhibitors on Emicizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Takeda
Related studies linked through entity extraction aliases.
A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy Participants
- Status
- TERMINATED
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori Infection
- Status
- COMPLETED
- Phase
- PHASE3
Quality Assurance of Secondary Immunodeficiencies (SID) in CLL/MM Patients
- Status
- COMPLETED
- Phase
- N/A
A Study of TAK-079 in People With Generalized Myasthenia Gravis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male Participants
- Status
- COMPLETED
- Phase
- PHASE1
Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment
- Status
- COMPLETED
- Phase
- N/A
A Study of People With Multiple Myeloma (MM) in Portugal (CharisMMa-Portugal)
- Status
- COMPLETED
- Phase
- N/A
TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion Mutations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal Fistula
- Status
- TERMINATED
- Phase
- PHASE4
Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After Treatment
- Status
- TERMINATED
- Phase
- N/A
A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy
- Status
- TERMINATED
- Phase
- PHASE2
Ixazomib + Pomalidomide + Dexamethasone In MM
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Study Augmenting TAK-659 Action in Relapsed/Refractory AML by Addition Ofthe Proteasome Inhibitor Ixazomib
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
- Status
- COMPLETED
- Phase
- PHASE3
A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
FIRAZYR General Drug Use-Results Survey (Japan)
- Status
- COMPLETED
- Phase
- N/A
Event-Related Potential (ERP) Biomarkers in Subjects With Schizophrenia and Healthy Volunteer Subjects
- Status
- COMPLETED
- Phase
- N/A